دورية أكاديمية

Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial

التفاصيل البيبلوغرافية
العنوان: Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial
المؤلفون: Basch, Ethan, Wood, William A., Schrag, Deborah, Sima, Camelia S., Shaw, Mary, Rogak, Lauren J., Kris, Mark G., Shouery, Marwan, Bennett, Antonia, Atkinson, Thomas, Catherine Pietanza
المصدر: Clinical Trials, 13(3)
سنة النشر: 2016
المجموعة: Carolina Digital Repository (UNC - University of North Carolina)
مصطلحات موضوعية: Lung Neoplasms, Patient-reported outcome, Antineoplastic Combined Chemotherapy Protocols, Humans, Carcinoma, Non-Small-Cell Lung, drug development, Female, Male, Feasibility Studies, Adult, adverse event, Clinical Trials, Phase II as Topic, Drug-Related Side Effects and Adverse Reactions, Bevacizumab, toxicity, clinical trial, Middle Aged, Aged, Information Dissemination
الوصف: Clinicians can miss up to half of patients’ symptomatic toxicities in cancer clinical trials and routine practice. Although patient-reported outcome questionnaires have been developed to capture this information, it is unclear whether clinicians will make use of patient-reported outcomes to inform their own toxicity documentation, or to prompt symptom management activities.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://doi.org/10.17615/x92c-cc93Test; https://cdr.lib.unc.edu/downloads/44558j98p?file=thumbnailTest; https://cdr.lib.unc.edu/downloads/44558j98pTest
DOI: 10.17615/x92c-cc93
الإتاحة: https://doi.org/10.17615/x92c-cc93Test
https://cdr.lib.unc.edu/downloads/44558j98p?file=thumbnailTest
https://cdr.lib.unc.edu/downloads/44558j98pTest
حقوق: http://rightsstatements.org/vocab/InC/1.0Test/
رقم الانضمام: edsbas.96CA6853
قاعدة البيانات: BASE